Latest News & Features
Medtech
The Federal Circuit upholds a ruling in favour of Microsoft against an Orlando tech company | Dispute concerned 3D medical imaging technology | Court affirms PTAB’s decision to invalidate most of the patent. 4 April 2024
Big Pharma
Senior pharma attorney and LSPN Boston speaker delves into emerging tech and patent law, the importance of communication and awareness, and the challenge of enablement | Advice on effective management of IP portfolios in the life sciences sector. 4 April 2024
Generics
Teva and co-appellant Mylan gain second chance at launching generics of Invega Sustenna, owned by J&J subsidiary Janssen | US Court of Appeals vacates a lower court’s decision to grant validity to the drug’s last remaining patent. 2 April 2024
Careers
Former Biogen counsel brings expertise in patent litigation for startups- Fortune 500 biotech giants | Experience in gene sequencing, computational biology, diagnostic software, and biosimilars. 2 April 2024
Generics
Judge disagrees that barrier against generic drug makers should be longer | Pharma company argues that ‘window should be shut’ on copycat versions due to potential for irreparable harm. 28 March 2024
Medtech
Roche patent attorney Matt Flinders shares his perspectives on the impact of emerging tech on patent law and strategy | Insights into the challenges companies are facing with emerging tech. 28 March 2024
Biotechnology
ERS Genomics, founded by CRISPR co-inventor Emmanuelle Charpentier, celebrates as China rejects invalidity challenges | News follows on heels of a similar Japan Patent Office decision. 26 March 2024
Medtech
Judge’s dissenting opinion challenges the interpretation of the safe harbour provision by the US Court of Appeals for the Federal Circuit | Decision concerns Meril's importation of transcatheter heart valve systems in a dispute with Edwards Lifesciences | Court majority upheld the district court's ruling favouring Meril. 26 March 2024
Plant Varieties
Applicants face tough scrutiny for claims around the laws of nature, but details of new processes, steps or guidance can help patents pass the courts’ two-step test, says Michael Taylor of Harness IP. 26 March 2024
Big Pharma
US Patent Trial and Appeal Board sides with the biotech pair in their challenge against Moderna's mRNA vaccine patents | Inter partes review challenges broad claims and monopolisation over mRNA tech. 21 March 2024